Shanghai, China

Weiliu Qiu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Shanghai Jiao Tong University. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Weiliu Qiu. Retrieved from https://idiyas.com/inventor/weiliu-qiu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Weiliu Qiu: Innovator in Tumor Treatment

Introduction

Weiliu Qiu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of novel compounds.

Latest Patents

Weiliu Qiu holds a patent for "Gambogenic acid derivatives, preparation method and application thereof." This patent describes gambogenic acid derivatives that exhibit a structure shown as Formula (I) or (II), along with their salts, preparation methods, and applications in tumor treatment. Compared to gambogenic acid, these derivatives demonstrate more potent anti-tumor activities. He has 1 patent to his name.

Career Highlights

Weiliu Qiu is affiliated with Shanghai Jiao Tong University, where he conducts his research. His work focuses on developing effective treatments for tumors, contributing to advancements in medical science.

Collaborations

He has collaborated with notable colleagues, including Wantao Chen and Xu Wang, to further enhance the impact of his research.

Conclusion

Weiliu Qiu's innovative work in developing gambogenic acid derivatives showcases his commitment to improving cancer treatment. His contributions are vital in the ongoing fight against tumors, and his research continues to inspire advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…